Announcements Trials
Browse Landscape

Phase

Phase NA 36Phase 2 7Phase 3 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1Phase 1 1

Status

Completed 7Unknown 3Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 7

Conditions

Breast Neoplasms 1277Carcinoma, Non-Small-Cell Lung 926Prostatic Neoplasms 729Neoplasms 632Multiple Myeloma 553Lymphoma 539Colorectal Neoplasms 529Lung Neoplasms 515Leukemia 497Leukemia, Myeloid, Acute 472Neoplasm Metastasis 470Melanoma 425Lymphoma, Non-Hodgkin 417Ovarian Neoplasms 416Leukemia, Lymphocytic, Chronic, B-Cell 386Pancreatic Neoplasms 373Recurrence 335Precursor Cell Lymphoblastic Leukemia-Lymphoma 327Head and Neck Neoplasms 306Lymphoma, Large B-Cell, Diffuse 294Glioblastoma 294Myelodysplastic Syndromes 287Brain Neoplasms 287Lymphoma, Follicular 286Stomach Neoplasms 280Carcinoma, Renal Cell 268Hodgkin Disease 261Carcinoma, Hepatocellular 261Rectal Neoplasms 256Sarcoma 250

Interventions

Paclitaxel 2palbociclib 1iniparib 1darolutamide 1Thioctic Acid 1Metformin 1Letrozole 1Doxorubicin 1Cyclophosphamide 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Completed × Breast Cancer Female × Clear all
NCT03747042 2026-03-16

Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer

University of Texas Southwestern Medical Center

Phase 2 Completed
61 enrolled 5 charts
Breast

Breast Cancer Female

NCT06975085 2026-02-12

Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study

University of Colorado, Denver

Phase 2 Completed
781 enrolled
Breast

Breast Cancer Female

NCT06703593 2025-10-01

Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients

British University In Egypt

Phase 2 Completed
80 enrolled
Breast

Breast Cancer Female

NCT03065621 2023-04-19

NeoRHEA

Jules Bordet Institute

Phase 2 Completed
100 enrolled
Breast

Breast Cancer Female

NCT03383679 2022-11-21

START

UNICANCER

Phase 2 Completed
94 enrolled
Breast

Breast Cancer Female

NCT04170465 2022-09-10

METNEO

Damanhour University

Phase 2 Completed
70 enrolled
Breast

Breast Cancer Female

NCT01204125 2017-03-22

SOLTI NEOPARP

Sanofi

Phase 2 Completed
141 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡